Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Intelligent Bio Solutions Inc INBS

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat... see more

Recent & Breaking News (NDAQ:INBS)

GBS INC. Announces Adjournment of 2022 Annual Meeting of Stockholders to July 13, 2022

GlobeNewswire June 16, 2022

GBS Inc. Enters into Exclusivity Agreement for an Acquisition of Unique Point of Care Diagnostic Screening Technology Focused on Opioids and Drugs of Abuse

GlobeNewswire June 16, 2022

GBS Inc. to Present at the H.C. Wainwright Global Investment Conference

GlobeNewswire May 16, 2022

GBS Inc. to Hold Virtual 2022 Annual Shareholder Meeting on Thursday, June 16, 2022, at 4:00pm ET

GlobeNewswire May 13, 2022

GBS Inc. Reports Third Quarter 2022 Financial Results and Recent Business Highlights

GlobeNewswire May 10, 2022

GBS Inc. to Present Third Quarter 2022 Financial Results and Recent Corporate Update on May 10

GlobeNewswire May 3, 2022

GBS Inc. Announces Institutional Review Board Approval to Initiate Clinical Trial at Sutter Health Mills-Peninsula Medical Center

GlobeNewswire March 31, 2022

GBS Inc. to Participate in the Upcoming March Investor Conferences

GlobeNewswire March 7, 2022

GBS Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights

GlobeNewswire February 10, 2022

GBS Inc. to Present Second Quarter 2022 Financial Results and Recent Corporate Update on February 10

GlobeNewswire February 7, 2022

GBS Inc. to Participate in the Upcoming January Virtual Investor Conferences

GlobeNewswire December 20, 2021

GBS Inc. Announces Application for FDA Breakthrough Device Designation to Fast Track Rapid Saliva Glucose Test

GlobeNewswire December 13, 2021

GBS Inc. Announces Plans for Clinical SARS-CoV-2 Antibody Trials Following Validation Study

GlobeNewswire November 30, 2021

GBS Inc. Reports First Quarter 2022 Financial Results and Recent Business Highlights

GlobeNewswire November 11, 2021

GBS Inc. to Present First Quarter 2022 Financial Results and Recent Corporate Update on November 11

GlobeNewswire November 1, 2021

GBS Inc. Announces Executive Leadership Changes to Accelerate Product Development and Manufacturing

GlobeNewswire November 1, 2021

GBS Inc. Announces its Pre-Submission package is with the FDA

GlobeNewswire October 13, 2021

GBS Inc. to Present at Upcoming September Virtual Investor Conferences

GlobeNewswire September 7, 2021

GBS Inc. Reports Fourth Quarter and Full Year 2021 Preliminary Financial Results and Recent Business Highlights

GlobeNewswire August 11, 2021

GBS Inc. to Present Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Update on August 11

GlobeNewswire July 29, 2021